On a humid May afternoon, seated in his Gurugram residence, Prashant Tandon speaks with the calm assurance of someone who has spent over a decade navigating both regulatory mazes and the challenges of one of the most complex sectors—healthcare.
As the co-founder and CEO of Tata 1mg, Tandon has been the steady hand guiding the company’s transformation from a medicine information app to one of India’s most prominent digital health platforms. This has seen him emerge as one of the most authoritative voices in healthcare.
Since its acquisition by the Tata Group in 2021, 1mg has evolved from an e-pharmacy into a full-stack outpatient healthcare business, offering diagnostics, teleconsultations, private label offerings, rapid medicine delivery, and most recently, offline retail and institutional healthcare.
This is a premium article and available only to subscribers.
Exclusive access to this article for 1 year.
What you get
Premium In-Depth Stories
5 articles every week
Archives
>3 years of archives
Newsletter
5 every week
Gifting Credit
5 premium articles every month
Visual Infographics
1 every week
Sessions
3 screens Concurrently
Upgrade how you think, work, and win — Freedom Sale is on!
Have a coupon code?
Access unlimited content at a special discounted rate. Trusted by top VC’s and leading organizations, we provide bulk subscriptions for groups of 30+. Contact us for more details
Top educational institutions have collaborated with us for campus-wide subscriptions. For bulk campus-wide access, please get in touch.
Join our community of 100,000+ top executives, VCs, entrepreneurs, and brightest student minds
Convinced that The Captable stories and insights
will give you the edge?
Convinced that The Captable stories
and insights will give you the edge?
Subscribe Now
Sign Up Now